The store will not work correctly when cookies are disabled.
US9394303, 4
ID: ALA3900178
Cas Number: 319923-90-5
PubChem CID: 7174615
Max Phase: Preclinical
Molecular Formula: C15H13N3O2
Molecular Weight: 267.29
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc(C(=O)O)c2c(C)nn(-c3ccccc3)c2n1
Standard InChI: InChI=1S/C15H13N3O2/c1-9-8-12(15(19)20)13-10(2)17-18(14(13)16-9)11-6-4-3-5-7-11/h3-8H,1-2H3,(H,19,20)
Standard InChI Key: GGNIHFFEYHWPQO-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
2.3383 -1.3500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0031 3.0008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0432 3.5994 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.0351 3.6026 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7248 1.2135 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0955 2.3548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6065 0.0000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.7248 -1.2135 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.1884 -2.6409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6234 -3.0602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9781 -4.5176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8933 -5.5536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4537 -5.1320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0990 -3.6745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 6 2 0
5 7 1 0
4 8 2 0
8 9 1 0
9 10 1 0
9 11 2 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
12 19 1 0
19 8 1 0
19 20 2 0
20 2 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 267.29 | Molecular Weight (Monoisotopic): 267.1008 | AlogP: 2.74 | #Rotatable Bonds: 2 |
Polar Surface Area: 68.01 | Molecular Species: ACID | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.52 | CX Basic pKa: 1.45 | CX LogP: 2.15 | CX LogD: -1.22 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.77 | Np Likeness Score: -1.69 |
References
1. (2016) Small molecule inhibitors of MCL-1 and uses thereof, |
2. Miyachi H, Yuzuriha T, Tabata R, Fukuda S, Nunomura K, Lin B, Kobayashi T, Ishimoto K, Doi T, Tachibana K.. (2019) Structural development of 1H-pyrazolo-[3,4-b]pyridine-4-carboxylic acid derivatives as human peroxisome proliferator-activated receptor alpha (PPARα)-selective agonists., 29 (16): [PMID:31320147] [10.1016/j.bmcl.2019.06.062] |